Back

Is the HNF4A gene variant paradoxically associated with better prognostic in CAD patients?

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease: genetic determinants and molecular phenotyping Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Debora Sa

Hospital Dr. Nelio Mendonca, Funchal (Portugal)

4 More presentations in this session

Presentation thumbnail
Circulating ACE2 and the association of endothelial progenitor cell in CAD patients
Doctor Y. Lu (Taichung, TW)
Abstract Slides Video
Presentation thumbnail
Aspirin inhibits atherosclerosis through macrophage pyroptosis by interacting with Lactobacillus johnsonii and its metabolite butyrate
Doctor H. Rui (Xi'an, CN)
Abstract Slides Video
Presentation thumbnail
Awareness and perceptions of cardiologists towards systemic inflammation in atherosclerotic cardiovascular disease: A multi-national survey across 5 geographical regional sub-groups
Professor A. Catapano (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Coronary Computed Tomographic Angiography (CCTA) in non-ST elevation acute coronary syndromes
Doctor I. Chapman (Buenos Aires, AR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease: genetic determinants and molecular phenotyping

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Progress in understanding the genetic underpinning of coronary artery disease: from genotype to phenotype
thumbnail
Congress Presentation
GJA4 gene inhibition may represent a potential target for novel antithrombotic therapies
thumbnail
Congress Presentation
Haptoglobin 1 gene polymorphism protects against postoperative cardiovascular events

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources